Beta Bionics (BBNX) was downgraded by
Weiss Ratings from "sell (d-)" to "sell (e+)".
Beta Bionics (BBNX) had its price target lowered by Leerink Partners from $25.00 to $24.00. They now have an "outperform" rating on the stock.
Beta Bionics (BBNX) had its price target lowered by Stifel Nicolaus from $22.00 to $20.00. They now have a "buy" rating on the stock.
Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5% [Seeking Alpha]
Beta Bionics, Inc. (BBNX) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]